From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis.
Saved in:
| Title: | From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis. |
|---|---|
| Authors: | Ghezzi L; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; IRCCS Foundation, Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy., Kosa P; Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Greenwood M; Department of Mathematical Sciences, Montana State University, Bozeman, MT, USA., Alvarez E; Department of Neurology, Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO, USA., Freedman CL; University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada., Cross AH; Department of Neurology, Washington University School of Medicine, St Louis, MI, USA., Pace F; Department of Neurology, Washington University School of Medicine, St Louis, MI, USA., Freedman MS; University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada., Kocot J; Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Piccio L; Charles Perkins Centre and Brain and Mind Centre, Neuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Bielekova B; Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. |
| Source: | Annals of neurology [Ann Neurol] 2026 Feb; Vol. 99 (2), pp. 328-340. Date of Electronic Publication: 2025 Oct 03. |
| Publication Type: | Journal Article; Multicenter Study; Validation Study |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41041831 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ghezzi+L%22">Ghezzi L</searchLink>; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; IRCCS Foundation, Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Kosa+P%22">Kosa P</searchLink>; Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Greenwood+M%22">Greenwood M</searchLink>; Department of Mathematical Sciences, Montana State University, Bozeman, MT, USA.<br /><searchLink fieldCode="AU" term="%22Alvarez+E%22">Alvarez E</searchLink>; Department of Neurology, Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Freedman+CL%22">Freedman CL</searchLink>; University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Cross+AH%22">Cross AH</searchLink>; Department of Neurology, Washington University School of Medicine, St Louis, MI, USA.<br /><searchLink fieldCode="AU" term="%22Pace+F%22">Pace F</searchLink>; Department of Neurology, Washington University School of Medicine, St Louis, MI, USA.<br /><searchLink fieldCode="AU" term="%22Freedman+MS%22">Freedman MS</searchLink>; University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Kocot+J%22">Kocot J</searchLink>; Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Piccio+L%22">Piccio L</searchLink>; Charles Perkins Centre and Brain and Mind Centre, Neuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Bielekova+B%22">Bielekova B</searchLink>; Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227707449%22">Annals of neurology</searchLink> [Ann Neurol] 2026 Feb; Vol. 99 (2), pp. 328-340. <i>Date of Electronic Publication: </i>2025 Oct 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Validation Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7707449 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1531-8249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203645134%22">03645134 </searchLink><i>NLM ISO Abbreviation: </i>Ann Neurol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41041831 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ana.78047 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 328 Titles: – TitleFull: From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ghezzi L – PersonEntity: Name: NameFull: Kosa P – PersonEntity: Name: NameFull: Greenwood M – PersonEntity: Name: NameFull: Alvarez E – PersonEntity: Name: NameFull: Freedman CL – PersonEntity: Name: NameFull: Cross AH – PersonEntity: Name: NameFull: Pace F – PersonEntity: Name: NameFull: Freedman MS – PersonEntity: Name: NameFull: Kocot J – PersonEntity: Name: NameFull: Piccio L – PersonEntity: Name: NameFull: Bielekova B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1531-8249 Numbering: – Type: volume Value: 99 – Type: issue Value: 2 Titles: – TitleFull: Annals of neurology Type: main |
| ResultId | 1 |